Virtus Biotech Clinical Trials ETF (BBC) एक सार्वजनिक रूप से कारोबार करने वाली कंपनी है में वित्तीय सेवाएं क्षेत्र, संचालन करती है Asset Management उद्योग.
BBC के पास है IPO तिथि 2014-12-17, पर सूचीबद्ध NYSE, बाजार पूंजीकरण $36.78M.
The Fund seeks investment results that correspond, before fees and expenses, to the price and yield performance of the LifeSci Biotechnology Clinical Trials Index, which tracks the performance of select clinical trials stage biotechnology companies.Effective February 27, this Fund's name changed from Virtus LifeSci Biotech Clinical Trials ETF to Virtus Biotech Clinical Trials ETF.
